143 related articles for article (PubMed ID: 18436192)
1. Antagonist-radioligand binding to D2L-receptors in intact cells.
Packeu A; De Backer JP; Van Liefde I; Vanderheyden PM; Vauquelin G
Biochem Pharmacol; 2008 Jun; 75(11):2192-203. PubMed ID: 18436192
[TBL] [Abstract][Full Text] [Related]
2. Antagonist-D2S-dopamine receptor interactions in intact recombinant Chinese hamster ovary cells [corrected].
Packeu A; Béghin T; De Backer JP; Vauquelin G
Fundam Clin Pharmacol; 2010 Jun; 24(3):293-303. PubMed ID: 20015228
[TBL] [Abstract][Full Text] [Related]
3. Non-competitive interaction between raclopride and spiperone on human D-receptors in intact Chinese hamster ovary cells.
Packeu A; De Backer JP; Vauquelin G
Fundam Clin Pharmacol; 2010 Jun; 24(3):283-91. PubMed ID: 19909349
[TBL] [Abstract][Full Text] [Related]
4. Zinc modulates antagonist interactions with D2-like dopamine receptors through distinct molecular mechanisms.
Schetz JA; Chu A; Sibley DR
J Pharmacol Exp Ther; 1999 May; 289(2):956-64. PubMed ID: 10215675
[TBL] [Abstract][Full Text] [Related]
5. D2 receptor occupancy in conscious rat brain is not significantly distinguished with [3H]-MNPA, [3H]-(+)-PHNO, and [3H]-raclopride.
Peng T; Zysk J; Dorff P; Elmore CS; Ström P; Malmquist J; Ding M; Tuke D; Werkheiser J; Widzowski D; Mrzljak L; Maier D
Synapse; 2010 Aug; 64(8):624-33. PubMed ID: 20340171
[TBL] [Abstract][Full Text] [Related]
6. Dopamine D2 receptor dimer formation: evidence from ligand binding.
Armstrong D; Strange PG
J Biol Chem; 2001 Jun; 276(25):22621-9. PubMed ID: 11278324
[TBL] [Abstract][Full Text] [Related]
7. Dopamine displaces [3H]domperidone from high-affinity sites of the dopamine D2 receptor, but not [3H]raclopride or [3H]spiperone in isotonic medium: Implications for human positron emission tomography.
Seeman P; Tallerico T; Ko F
Synapse; 2003 Sep; 49(4):209-15. PubMed ID: 12827639
[TBL] [Abstract][Full Text] [Related]
8. Antagonist binding characteristics of the Ser311-->Cys variant of human dopamine D2 receptor in vivo and in vitro.
Pohjalainen T; Cravchik A; Gejman PV; Rinne J; Någren K; Syvälahti E; Hietala J
Biochem Biophys Res Commun; 1997 Mar; 232(1):143-6. PubMed ID: 9125119
[TBL] [Abstract][Full Text] [Related]
9. Investigation of cooperativity in the binding of ligands to the D(2) dopamine receptor.
Vivo M; Lin H; Strange PG
Mol Pharmacol; 2006 Jan; 69(1):226-35. PubMed ID: 16204468
[TBL] [Abstract][Full Text] [Related]
10. Sequestration of the short and long isoforms of dopamine D2 receptors expressed in Chinese hamster ovary cells.
Itokawa M; Toru M; Ito K; Tsuga H; Kameyama K; Haga T; Arinami T; Hamaguchi H
Mol Pharmacol; 1996 Mar; 49(3):560-6. PubMed ID: 8643097
[TBL] [Abstract][Full Text] [Related]
11. Hypothermia reduces the rate of dissociation of specific ligands from dopamine-D2 and 5-hydroxytryptamine1A receptors in the mouse brain in vivo.
Stenfors C; Ross SB
Naunyn Schmiedebergs Arch Pharmacol; 2001 Nov; 364(5):479-86. PubMed ID: 11692232
[TBL] [Abstract][Full Text] [Related]
12. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent: I. Receptor-binding profile and functional actions at G-protein-coupled receptors.
Millan MJ; Mannoury la Cour C; Novi F; Maggio R; Audinot V; Newman-Tancredi A; Cussac D; Pasteau V; Boutin JA; Dubuffet T; Lavielle G
J Pharmacol Exp Ther; 2008 Feb; 324(2):587-99. PubMed ID: 18024789
[TBL] [Abstract][Full Text] [Related]
13. [3H] A-369508 ([2-[4-(2-cyanophenyl)-1-piperazinyl]-N-(3-methylphenyl) acetamide): an agonist radioligand selective for the dopamine D4 receptor.
Moreland RB; Terranova MA; Chang R; Uchic ME; Matulenko MA; Surber BW; Stewart AO; Brioni JD
Eur J Pharmacol; 2004 Aug; 497(2):147-54. PubMed ID: 15306199
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D2(High) receptors on intact cells.
Seeman P
Synapse; 2008 Apr; 62(4):314-8. PubMed ID: 18241049
[TBL] [Abstract][Full Text] [Related]
15. In vitro biochemical evidence that the psychotomimetics phencyclidine, ketamine and dizocilpine (MK-801) are inactive at cloned human and rat dopamine D2 receptors.
Jordan S; Chen R; Fernalld R; Johnson J; Regardie K; Kambayashi J; Tadori Y; Kitagawa H; Kikuchi T
Eur J Pharmacol; 2006 Jul; 540(1-3):53-6. PubMed ID: 16730695
[TBL] [Abstract][Full Text] [Related]
16. Aripiprazole's low intrinsic activities at human dopamine D2L and D2S receptors render it a unique antipsychotic.
Tadori Y; Miwa T; Tottori K; Burris KD; Stark A; Mori T; Kikuchi T
Eur J Pharmacol; 2005 May; 515(1-3):10-9. PubMed ID: 15894311
[TBL] [Abstract][Full Text] [Related]
17. Amphetamine-sensitized animals show a marked increase in dopamine D2 high receptors occupied by endogenous dopamine, even in the absence of acute challenges.
Seeman P; Tallerico T; Ko F; Tenn C; Kapur S
Synapse; 2002 Dec; 46(4):235-9. PubMed ID: 12373738
[TBL] [Abstract][Full Text] [Related]
18. Structural determinants of pharmacological specificity between D(1) and D(2) dopamine receptors.
Lan H; Durand CJ; Teeter MM; Neve KA
Mol Pharmacol; 2006 Jan; 69(1):185-94. PubMed ID: 16236817
[TBL] [Abstract][Full Text] [Related]
19. Competitive MS binding assays for dopamine D2 receptors employing spiperone as a native marker.
Niessen KV; Höfner G; Wanner KT
Chembiochem; 2005 Oct; 6(10):1769-75. PubMed ID: 16149041
[TBL] [Abstract][Full Text] [Related]
20. Increased affinity of dopamine for D(2) -like versus D(1) -like receptors. Relevance for volume transmission in interpreting PET findings.
Marcellino D; Kehr J; Agnati LF; Fuxe K
Synapse; 2012 Mar; 66(3):196-203. PubMed ID: 22034017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
